Trevi Therapeutics, Inc. (TRVI) earnings date

Nasdaq · Small cap · EDGAR filings

Email me when this date changes · free account, one click to stop

How this company behaves

Announces its report date Not enough announcements on file yet to say
Reports after the quarter ends 39 days, typically, give or take 18 (last 8 releases)

Last 8 releases

PeriodReleasedTimingDays after period endFiling
Q3 FY2026Mon, Nov 9, 2026after close 40 8-K
Q2 FY2026Thu, Aug 6, 2026after close 37 8-K
Q1 FY2026Tue, May 5, 2026after close 35 8-K
Q4 FY2025Tue, Mar 17, 2026after close 76 8-K
Q3 FY2025Thu, Nov 13, 2025after close 44 8-K
Q2 FY2025Thu, Aug 7, 2025after close 38 8-K
Q1 FY2025Thu, May 8, 2025after close 38 8-K
Q4 FY2024Tue, Mar 18, 2025after close 77 8-K

What they guided beta

Q3 FY2026 "Exhibit 99.1 Trevi Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Updates Initiated Phase 3 OCEAN-2 trial for patients with IPF-related chronic cough in the third quarter; both Phase 3 OCEAN trials actively recruiting Positive meeting with the FDA on the non-IPF ILD-related chronic cough program held in October 2026; Phase 2 dose-ranging trial expected to initiate in the first quarter of 2027 Notice of Allowance from the USPTO for patent application covering nalbuphine ER dosing in hepatically impaired patients with non-IPF ILD-related chronic cough, with pa" exhibit
Q3 FY2026 "“We also recently aligned with the FDA on our non-IPF ILD-related chronic cough program and expect to initiate a Phase 2 dose-ranging trial in the first quarter of 2027." exhibit
Q3 FY2026 "The 12-week fixed-dose OCEAN-2 trial , was initiated in the third quarter of 2026, and topline results are expected in the second half of 2027." exhibit
Q3 FY2026 "The 52-week fixed-dose OCEAN-1 trial was initiated in the second quarter of 2026, and topline results are expected in the first half of 2028." exhibit
Q3 FY2026 "The Company expects to initiate the trial in the first quarter of 2027, subject to review of the trial protocol by the FDA, and topline results are expected in the first half of 2028." exhibit
Q2 FY2026 "Exhibit 99.1 Trevi Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Updates Initiated Phase 3 OCEAN-1 trial for patients with idiopathic pulmonary fibrosis-related chronic cough in the second quarter; Phase 3 OCEAN-2 trial expected to initiate in the third quarter of 2026 Initiated Phase 2b LAKE trial for patients with refractory chronic cough in the second quarter; sample size re-estimation expected in the fourth quarter of 2026 Management to host a conference call and webcast today at 4:30 p.m. ET New Haven, Conn., August 6, 2026 – Trevi Therapeutics, Inc." exhibit
Q2 FY2026 "We expect to initiate our second Phase 3 trial in IPF-related chronic cough during the third quarter and meet with the FDA regarding our planned non-IPF ILD-related chronic cough trial,” said Jennifer Good, President and CEO of Trevi Therapeutics." exhibit
Q2 FY2026 "Topline data from the 52-week fixed dosing OCEAN-1 trial is expected in the first half of 2028." exhibit
Q2 FY2026 "The Company plans to initiate the 12-week fixed dosing OCEAN-2 trial, in the third quarter of 2026, with topline results expected in the second half of 2027." exhibit
Q2 FY2026 "The protocol includes a sample size re-estimation (SSRE) analysis once 50% of the participants complete treatment which is expected to occur in the fourth quarter of 2026." exhibit

Get this as JSON

curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/next/TRVI
# how far back the record goes for this company
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/coverage/TRVI

Put this date on your page

A badge that stays current. It links back to this page and needs no key. Embed it unmodified, with its link to this page intact: the badge is too small to carry the notice below, so the page it links to does.

Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.

TRVI earnings date badge

HTML

<a href="https://veritasdata.dev/company/TRVI/"><img src="https://veritasdata.dev/embed/TRVI.svg" alt="TRVI earnings date" width="240" height="56"></a>

Markdown

[![TRVI earnings date](https://veritasdata.dev/embed/TRVI.svg)](https://veritasdata.dev/company/TRVI/)

Script

<script async src="https://veritasdata.dev/embed/TRVI.js"></script>

Get a free key: 100 calls, every company

Sign in with GitHub or Google. The key works on every endpoint and in the MCP server.

curl -H "X-API-Key: vt_live_..." "https://api.veritasdata.dev/v1/next/TRVI"

Dates come only from SEC EDGAR and company announcements. Nothing here is investment advice.